A review of new developments in type 2 diabetes in human beings and cats
- 31 December 1993
- journal article
- research article
- Published by Elsevier in British Veterinary Journal
- Vol. 149 (6), 527-536
- https://doi.org/10.1016/s0007-1935(05)80037-5
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Amylin injection causes elevated plasma lactate and glucose in the ratFEBS Letters, 1991
- Co-secretion of amylin and insulin from cultured islet β-cells: Modulation by nutrient secretagogues, islet hormones and hypoglycemic agentsBiochemical and Biophysical Research Communications, 1991
- Release of amylin from perfused rat pancreas in response to glucose, arginine, beta-hydroxybutyrate, and gliclazideDiabetes, 1991
- Amylin activates glycogen phosphorylase in the isolated soleus muscle of the ratFEBS Letters, 1991
- Banting lecture 1990. Beta-cells in type II diabetes mellitusDiabetes, 1991
- Amylin activates glycogen phosphorylase and inactivates glycogen synthase via a cAMP-independent mechanismBiochemical and Biophysical Research Communications, 1991
- The putative hormone islet amyloid polypeptide (IAPP) induces impaired glucose tolerance in catsBiochemical and Biophysical Research Communications, 1990
- Secretion of islet amyloid polypeptide in response to glucoseFEBS Letters, 1989
- Islet Amyloid, Islet-Amyloid Polypeptide, and Diabetes MellitusNew England Journal of Medicine, 1989
- IMMUNOASSAY OF ENDOGENOUS PLASMA INSULIN IN MANJCI Insight, 1960